Heart & Vascular
Sub Category
Study Name
Fourier: A Double-blind, randomized, placebo-controlled, Multicenter Study assessing the Impact of Additional LDL Cholesterol Reduction on Major Cardiovascular Events when AMG 145 is Used in Combination with Statin Therapy in Patients with Clinically Evident Cardiovascular Disease
Principal Investigator
David Strobl, DO
Study Information
Patients must be 40-85 years old with a history oc cardiovascular disease and risk factors Must not have Heart Failure class III or IV or have had a stroke Must be willing to use self injector pens
Contact for Questions
Sparrow Clinical Research Institute 517-364-5760

Site view: at a glance